NEWPORT BEACH, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- via IBN -- ROTH MKM and Sustain Southern California (“Sustain SoCal”) today announced that they are jointly hosting the 6th Annual ...

It's an annual tradition – when we put together end-of-year "best of" lists, we inevitably come across something shiny and new that could have made the list had we previously covered it. In this case, ...

Roth MKM lowered the firm’s price target on Curaleaf (CURLF) to $5 from $7 but keeps a Buy rating on the shares. The company reported a modest decrease in Q3 top-line growth but improved margins, as ...

Roth MKM raised the firm’s price target on D-Wave Quantum (QBTS) to $7 from $3 and keeps a Buy rating on the shares. The company has announced a new common stock sale agreement as a follow-on to its ...

On Friday, Roth/MKM began coverage on shares of HF Foods Group Inc (NASDAQ:HFFG), assigning a Buy rating with a price target of $7.00. Currently trading at $3.90, InvestingPro analysis indicates the ...

ALMATY, KAZAKHSTAN and STAMFORD, CT / ACCESSWIRE / December 3, 2021 / Freedom Holding Corp. (NASDAQ:FRHC) ("Freedom") has entered an agreement to acquire MKM Partners, LLC ("MKM Partners"), it was ...

Investing.com - Roth/MKM has raised its price target on Airgain (NASDAQ: AIRG) to $7.50 from $7.00 while maintaining a Buy rating on the stock. Currently trading at $4.68, InvestingPro analysis ...

Detailed price information for Niagen Bioscience Inc (NAGE-Q) from The Globe and Mail including charting and trades.

PROMOTIONAL goods and marketing company MKM Group posted a £7.4m loss today after pulling out of its recession-hit Australian business. The Timperley, Greater Manchester-based firm, which is listed on ...

Investing.com - Roth/MKM has raised its price target on MBIA Inc. (NYSE: MBI) to $7.00 from $5.00 while maintaining a Neutral rating on the stock. The insurance company, currently trading at $6.52 ...

Gift 5 articles to anyone you choose each month when you subscribe. Non bank mortgage lender MKM Capital has snapped up a $300 million portfolio of residential prime and non-conforming mortgages.